Market Overview

Next-Generation Sequencing (NovaSeq, NextSeq, Sequel, Nanopore) Market - Global Forecasts to 2024 - ResearchAndMarkets.com

Share:

The "Next-Generation
Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore),
Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology
(Ion, SMRT), Application (Diagnostics, Cancer), End User - Global
Forecasts to 2024"
report has been added to ResearchAndMarkets.com's
offering.

The global next-generation sequencing market is projected to reach USD
16.35 billion by 2024 from USD 5.70 billion in 2018, at a CAGR of 19.2%.

Factors such as advancements in NGS platforms, declining NGS capital
cost coupled with decreasing cost of sequencing, improving regulatory &
reimbursement scenario for NGS-based diagnostic tests, initiatives from
government & private bodies for large-scale sequencing projects, and
increasing application of NGS in precision medicine & molecular
diagnostics are expected to propel the growth of this market.

However, end-user budget constraints in developing nations are expected
to restrain the growth of the next-generation sequencing market in the
forecast period.

The next-generation sequencing market, by technology, is segmented into
sequencing by synthesis, ion semiconductor sequencing, single-molecule
real-time sequencing, nanopore sequencing, and other sequencing
technologies. The sequencing by synthesis segment is expected to command
the largest share of the next-generation sequencing market in 2018.

The large share of this segment can be attributed to the continuous
advancements in SBS technology-based consumables and NGS bioinformatics
solutions as well as the launch of advanced cost- & time-efficient
platforms based on SBS technology.

On the basis of end user, the next-generation sequencing market is
segmented into academic institutes & research centers, hospitals &
clinics, pharmaceutical & biotechnology companies, and other end users.
The hospitals & clinics segment is estimated to witness the highest
growth rate during the forecast period.

The high growth in this segment can be attributed to the development of
advanced NGS-based diagnostic solutions and growing number of agreements
between companies and hospitals for developing advanced tests and
products catering to the specific needs of hospitals and clinics.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Next-Generation Sequencing Market, By Product & Service

7 Next-Generation Sequencing Market, By Technology

8 Next-Generation Sequencing Market, By Application

9 Next-Generation Sequencing Market, By End User

10 Next-Generation Sequencing Market, By Region

11 Competitive Landscape

12 Company Profiles

  • 10x Genomics
  • Agilent Technologies, Inc.
  • Beckman Coulter (A Subsidiary of Danaher)
  • Becton, Dickinson and Company
  • BGI
  • Eurofins Scientific
  • F. Hoffmann-La Roche AG
  • Genewiz
  • Illumina, Inc.
  • Macrogen, Inc.
  • Oxford Nanopore Technologies, Ltd.
  • Pacific Biosciences of California, Inc.
  • Perkinelmer, Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

For more information about this report visit https://www.researchandmarkets.com/research/j8gs4g/nextgeneration?w=4

View Comments and Join the Discussion!